Cohen Jacob D. has filed 17 insider transactions across 1 company since June 2024.
Most recent transaction: a disposition of 83333 shares of MANGOCEUTICALS, INC. ($MGRX) on March 16, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | D | Stock Option (right to buy) | 83333 | $0.00 | 0.0000 | 13,883,103 | 100.00% | 0.60% |
| March 16, 2026 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | A | Stock Option (right to buy) | 2000000 | $0.00 | 2,000,000.0000 | 13,883,103 | 9999.99% | 14.41% |
| March 16, 2026 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | D | Stock Option (right to buy) | 2000000 | $0.00 | 0.0000 | 13,883,103 | 100.00% | 14.41% |
| March 16, 2026 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | A | Stock Option (right to buy) | 83333 | $0.00 | 83,333.0000 | 13,883,103 | 9999.99% | 0.60% |
| June 5, 2025 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | G | Common Stock | 200000 | $0.00 | 0.0000 | 93,731 | 100.00% | 100.00% |
| June 5, 2025 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | G | Common Stock | 200000 | $0.00 | 805,000.0000 | 93,731 | 33.06% | 100.00% |
| Sept. 9, 2025 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | A | Common Stock | 500000 | $0.00 | 500,000.0000 | 93,731 | 9999.99% | 100.00% |
| July 21, 2025 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | A | Convertible Promissory Note | 100000 | $0.00 | 100,000.0000 | 93,731 | 9999.99% | 100.00% |
| July 21, 2025 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | A | Warrant to Purchase Common Stock | 50000 | $0.00 | 50,000.0000 | 93,731 | 9999.99% | 53.34% |
| Sept. 9, 2025 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | A | Stock Option (right to buy) | 2000000 | $0.00 | 2,000,000.0000 | 93,731 | 9999.99% | 100.00% |
| March 16, 2026 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | D | Stock Option (right to buy) | 50000 | $0.00 | 0.0000 | 13,883,103 | 100.00% | 0.36% |
| March 16, 2026 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 13,883,103 | 9999.99% | 0.36% |
| April 10, 2025 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | A | Common Stock | 200000 | $0.00 | 805,000.0000 | 3,245,641 | 33.06% | 6.16% |
| April 10, 2025 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | A | Common Stock | 200000 | $0.00 | 805,000.0000 | 3,245,641 | 33.06% | 6.16% |
| Aug. 26, 2024 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | G | Common Stock | 800000 | $0.00 | 9,075,000.0000 | 1,427,967 | 9.67% | 56.02% |
| Aug. 26, 2024 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | G | Common Stock | 800000 | $0.00 | 0.0000 | 1,427,967 | 100.00% | 56.02% |
| June 3, 2024 | MANGOCEUTICALS, INC. | $MGRX | Cohen Jacob D. | Chief Executive Officer | A | Common Stock | 800000 | $0.00 | 9,075,000.0000 | 1,427,967 | 9.67% | 56.02% |